Product
ELAPRASE
1 clinical trial
2 indications
Indication
MucopolysaccharidosisIndication
Mucopolysaccharidosis II (MPS II)Clinical trial
An Open-label, Multicenter, Phase 4 Study to Assess the Effects of a Prophylactic Immune Tolerizing Regimen in MPS II Treatment-Naïve Patients Planned to Receive ELAPRASE Who Are at Risk of Developing Persistent Neutralizing AntibodiesStatus: Recruiting, Estimated PCD: 2027-06-15